Abcam Investor Relations Material
Latest events
H2 2022
Abcam
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Abcam plc
Access all reports
Abcam plc is a global provider of life science research tools, specializing in the development and marketing of reagents and tools essential for research in the life sciences sector. The company's extensive product range includes primary and secondary antibodies, immunoassay kits, cellular and biochemical assays, proteins and peptides, as well as products for cell and tissue imaging. Abcam serves a broad array of customers including researchers in academia, clinical labs, and pharmaceutical, biotech, and diagnostic companies. Abcam is headquartered in Cambridge, Cambridgeshire, UK, and its shares are listed on the Nasdaq.
Latest articles
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Anthony Noto: The Multifaceted CEO of SoFi
Anthony Noto built a successful and diverse career across multiple industries before becoming CEO of the fintech company SoFi.
9 Dec 2024
Master of Tickets: Breaking Down Live Nation Entertainment
Since merging in 2010, Ticketmaster and Live Nation have built an expansive ecosystem that dominates global live entertainment.
6 Dec 2024
Ticker symbol
ABCM
Country
🇺🇸 United States